Compare · AIDX vs ULS
AIDX vs ULS
Side-by-side comparison of 20/20 Biolabs Inc. (AIDX) and UL Solutions Inc. (ULS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AIDX and ULS operate in Precision Instruments (Health Care), so they compete in similar markets.
- ULS is the larger of the two at $17.23B, about 2863.6x AIDX ($6.0M).
- Over the past year, AIDX is down 97.4% and ULS is up 22.0% - ULS leads by 119.4 points.
- ULS has been more active in the news (4 items in the past 4 weeks vs 3 for AIDX).
- ULS has more recent analyst coverage (7 ratings vs 0 for AIDX).
PerformanceAIDX-97.41%ULS+3.24%
2026-02-19+0.00%2026-07-24
- Company
- 20/20 Biolabs Inc.
- UL Solutions Inc.
- Price
- $0.53+0.21%
- $85.49-1.26%
- Market cap
- $6.0M
- $17.23B
- 1M return
- -7.14%
- -7.54%
- 1Y return
- -97.41%
- +22.03%
- Industry
- Precision Instruments
- Precision Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2024
- News (4w)
- 3
- 4
- Recent ratings
- 0
- 7
Latest AIDX
- 20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock
- 20/20 Biolabs Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- 20/20 BioLabs Highlights Investor Webinar Focused on OneTest™ for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth
- 20/20 Biolabs Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form DEFA14A filed by 20/20 Biolabs Inc.
- SEC Form DEF 14A filed by 20/20 Biolabs Inc.
- 20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month
- SEC Form PRE 14A filed by 20/20 Biolabs Inc.
- 20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters
- 20/20 Biolabs Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Latest ULS
- UL Solutions Sets Date for Second Quarter Results
- UL Solutions Inc. upgraded by UBS with a new price target
- SEC Form 4 filed by Director Thaman Michael H
- SEC Form 4 filed by Director Kini Vikram
- President and CEO Scanlon Jennifer F. sold $1,240,277 worth of shares (12,500 units at $99.22) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 164,224 units (SEC Form 4)
- SEC Form 144 filed by UL Solutions Inc.
- UL Solutions Warns of Unauthorized UL Marks on Water-Based Fire Extinguishers
- UL Solutions Opens Advanced Automotive Electromagnetic Compatibility Laboratory in Japan
- UL Solutions Issues Its First Certification for a Remotely Operated Robot Designed for Hazardous Locations
- SEC Form 4 filed by Director Williams George A